The technology explained
RIBOSTEALTHTM
Despite its similarity to naturally occurring mRNA, exogenous IVT mRNA is inherently immunostimulatory. This poses a significant challenge for the use of mRNA in research and therapeutic applications. To achieve the desired effect without triggering excessive immune response, it is crucial to reduce the immunostimulatory potential of IVT mRNA. Some use modified nucleotides to reduce the immune response, however this may induce ribosomal misinterpretation, leading to stop codon read-through and frameshifts possibly resulting in auto-immunity-inducing mis incorporated amino acids, which is critical for (repeated) therapeutics.
The RIBOSTEALTHTM technology reduces, and potentially prevents, the induction of innate immunity against the mRNA, which is particularly important for repeated therapeutic use. Moreover, you will be seeing the benefits of:
• Increased Stability: Modified mRNA is less prone to degradation, ensuring longer-lasting effects.
• Enhanced Activity: Deimmunized mRNA maintains its function without unnecessary immune interference.
• Clarity and cooperation on the IP: dealing with only RIBOPRO, who has a strong commitment to your success and market entry.